A comparison of dopaminergic cells from the human NTera2/D1 cell line transplanted into the hemiparkinsonian rat

Life Sciences

Volumn 81, Issue 6, 2007, Pages 441-448

  Newcomb, J D ^a   Janowski, M ^a,b   Zigova, T ^a   Saporta, S ^a   McGrogan, M P ^c   Sanberg, P R ^a   Willing, A E ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c Layton BioScience Inc   (United States)

Author keywords

Apomorphine; hNT; Parkinson's Disease; Retinoic acid; Transplantation

Indexed keywords

ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; CYTOCHEMISTRY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; EMBRYO; EXPERIMENTAL RAT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NEUROCHEMISTRY; PARKINSONISM; PHENOTYPE; PROTEIN EXPRESSION;

ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; CELL LINE; CELL TRANSPLANTATION; DOPAMINE; DOPAMINE AGONISTS; GRAFT SURVIVAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; STEREOTYPED BEHAVIOR; SYMPATHOLYTICS; TYROSINE 3-MONOOXYGENASE;

PARKINSONIA; RATTUS;

EID: 34547487980     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.05.025     Document Type: Article

References (45)

1. Abercrombie M. Estimation of nuclear population from microtome sections. The Anatomical Record 94 (1946) 239-247
2. Agid Y. Parkinson's disease: pathophysiology. The Lancet 337 8753 (1991) 1321-1324
3. Andrews P.W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Developmental Biology 103 2 (1984) 285-293
4. Andrews P.W., Damjanov I., Simon D., Banting G.S., Carlin C., Dracopoli N.C., and Føgh J. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line tera-2. Laboratory Investigation 50 2 (1984) 147-162
5. Baker K.A., Hong M., Sadi D., and Mendez I. Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease. Experimental Neurology 162 2 (2000) 350-360
6. Barker R.A. Repairing the brain in Parkinson's disease: where next?. Movement Disorders 17 2 (2002) 233-241
7. Björklund L.M., Sánchez-Pernaute R., Chung S., Andersson T., Chen I.Y.C., McNaught K.St.P., Brownell A.-L., Jenkins B.G., Wahlestedt C., Kim K.-S., and Isacson O. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proceedings of the National Academy of Sciences 99 4 (2002) 2344-2349
8. Castañeda E., Whishaw I.Q., and Robinson T.E. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. The Journal of Neuroscience 10 6 (1990) 1847-1854
9. Christie S.D., Sadi D., and Mendez I. Intraspinal transplantation of hNT in the lesioned adult rat spinal cord. Canadian Journal of Neurological Sciences 31 1 (2004) 87-96
10. Emerich D.F., Ragozzino M., Lehman M.N., and Sanberg P.R. Behavioral effects of neural transplantation. Cell Transplantation 1 6 (1992) 401-427
11. Freed W.J. A perspective on transplantation therapy and stem cells for Parkinson's disease. Cell Transplantation 13 3 (2004) 319-327
12. Freed C.R., Greene P.E., Breeze R.E., Tsai W.-Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., and Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. New England Journal of Medicine 344 10 (2001) 710-719
13. Freed C.R., Leehey M.A., Zawanda M., Bjugstad K., Thompson L., and Breeze R.E. Do patients with Parkinson's disease benefit from embryonic dopamine cell transplantation?. Journal of Neurology 250 Suppl 3 (2003) III44-III46
14. Fricker-Gates R.A., Muir J.A., and Dunett S.B. Transplanted hNT cells ("LBS neurons") in a rat models of Huntington's disease: good survival, incomplete differentiation, and limited functional recovery. Cell Transplantation 13 2 (2004) 123-136
15. Garbuzova-Davis S., Willing A.E., Milliken M., Saporta S., Zigova T., Cahill D.W., and Sanberg P.R. Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis. Experimental Neurology 174 2 (2002) 169-180
16. Gelb D.J., Oliver E., and Gilman S. Diagnostic criteria for Parkinson's disease. Archives of Neurology 56 1 (1999) 33-39
17. Hagell P., Crabb L., Pogarell O., Schrag A., Widner H., Brooks D.J., Oertel W.H., Quinn N.P., and Lindvall O. Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease. Movement Disorders 15 2 (2000) 224-229
18. Hagell P., Piccini P., Björklund A., Brundin P., Rehncrona S., Widner H., Crabb L., Pavese N., Oertel W.H., Quinn N., Brooks D.J., and Lindval O. Dyskinesias following neural transplantation in Parkinson's disease. Nature Neuroscience 5 7 (2002) 627-628
19. Hebb M.O., and Robertson H.A. Motor effects and mapping of cerebral alterations in animal models of Parkinson's and Huntington's diseases. Journal of Comparative Neurology 410 1 (1999) 99-114
20. Hurlbert M.S., Gianani R.I., Hutt C., Freed C.R., and Kaddis F.G. Neural transplantation of hNT neurons for Huntington's disease. Cell Transplantation 8 1 (1999) 143-151
21. Kim J.-H., Auerbach J.M., Rodríguez-Gómez J.A., Velasco I., Gavin D., Lumelsky N., Lee S.-H., Nguyen J., Sánchez-Pernaute R., Bankiewicz K., and McKay R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418 6893 (2002) 50-56
22. Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J.G., Mufson E.J., Sanberg P.R., Hauser R.A., Smith D.A., Nauert G.M., Perl D.P., and Olanow C.W. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. New England Journal of Medicine 332 17 (1995) 1118-1124
23. Kösel S., Hofhaus G., Maassen A., Vieregge P., and Graeber M.B. Role of mitochondria in Parkinson's disease. Biological Chemistry 380 7-8 (1999) 865-870
24. Lazic S.E., and Barker R.A. The future of cell-based transplantation therapies for neurodegenerative disorders. Journal of Hematotherapy and Stem Cell Research 12 6 (2003) 635-642
25. Lindvall O., and Hagell P. Cell therapy and transplantation in Parkinson's disease. Clinical Chemistry and Laboratory Medicine 39 4 (2001) 356-361
26. Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., Leenders K.L., Sawle G., Rothwell J.C., and Marsden C.D. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247 4942 (1990) 574-577
27. Misiuta I.E., Anderson L., McGrogan M.P., Sanberg P.R., Willing A.E., and Zigova T. The transcription factor Nurr1 in human NT2 cells and hNT neurons. Developmental Brain Research 145 1 (2003) 107-115
28. Perrier A.L., and Studer L. Making and repairing the mammalian brain-in vitro production of dopaminergic neurons. Seminars in Cell and Developmental Biology 14 3 (2003) 181-189
29. Pleasure S.J., and Lee V.M.-Y. NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. Journal of Neuroscience Research 35 6 (1993) 585-602
30. Pleasure S.J., Page C.D., and Lee V.M.-Y. Pure, postmitotic polarized human neurons derived from NTera2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. Journal of Neuroscience 12 5 (1992) 1802-1815
31. Poulter M.O., Payne K.B., and Steiner J.P. Neuroimmunophilins: a novel drug therapy for the reversal of neurodegenerative disease?. Neuroscience 128 1 (2004) 1-6
32. Rivas-Arancibia S., Willing A.E., Zigova T., Rodriguez A.I., Cahill D.W., and Sanberg P.R. The effects of taurine on hNT neurons transplanted in adult rat striatum. Cell Transplantation 9 6 (2000) 751-758
33. Robinson T.E., and Whishaw I.Q. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Research 450 (1988) 209-224
34. Saporta S., Makoui A.S., Willing A.E., Daadi M., Cahill D.W., and Sanberg P.R. Functional recovery after complete contusion injury to the spinal cord and transplantation of human neuroteratocarcinoma neurons in rats. Journal of Neurosurgery. Spine 97 1 Suppl (2002) 63-68
35. Sodja C., Fang H., Dasgupta T., Ribecco M., Walker M.R.P.R., and Sikorska M. Identification of functional dopamine receptors in human teratocarcinoma NT2 cells. Molecular Brain Research 99 2 (2002) 83-91
36. Spencer C.M., Goa K.L., and Gillis J.C. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 54 6 (1997) 925-975
37. Willing A.E., Cameron D.F., and Sanberg P.R. Sertoli cell transplants: their use in the treatment of neurodegenerative disease. Molecular Medicine Today 4 11 (1998) 459-504
38. Willing A.E., Othberg A.I., Saporta S., Anton A., Sinibaldi S., Poulos S.G., Cameron D.F., Freeman T.B., and Sanberg P.R. Sertoli cells enhance the survival of co-transplanted dopamine neurons. Brain Research 822 1-2 (1999) 246-250
39. Willing A.E., Sudberry J.J., Othberg A.I., Saporta S., Poulos S.G., Cameron D.F., Freeman T.B., and Sanberg P.R. Sertoli cells decrease microglial response and increase engraftment of human hNT neurons in the hemiparkinsonian rat striatum. Brain Research Bulletin 48 4 (1999) 441-444
40. Willing A.E., Garbuzova-Davis S., Saporta S., Milliken M., Cahill D.W., and Sanberg P.R. hNT neurons delay onset of motor deficits in a model of amyotrophic lateral sclerosis. Brain Research Bulletin 56 6 (2001) 525-530
41. Willing A.E., Saporta S., Lixian J., Milliken M., Poulos S., Bowersox S.S., and Sanberg P.R. Preliminary study of the behavioral effects of LBS-neuron implantation on seizure susceptibility following middle cerebral artery occlusion in the rat. Neurotoxicity Research 4 2 (2002) 111-118
42. Willing A.E., Zigova T., Milliken M., Poulos S., Saporta S., McGrogan M.P., Snable G., and Sanberg G. Lithium exposure enhances survival of NT2N cells (hNT neurons) in the hemiparkinsonian rat. European Journal of Neuroscience 16 12 (2002) 2271-2278
43. Wolterink G., Van Zanten E., Kamsteeg H., Radhakishun F.S., and Van Ree J.M. Functional recovery after destruction of dopamine systems in the nucleus accumbens of rats. I. Behavioral and biochemical studies. Brain Research 507 1 (1990) 92-100
44. Zigova T., Barroso L.F., Willing A.E., Saporta S., McGrogan M.P., Freeman T.B., and Sanberg P.R. Dopaminergic phenotype of hNT cells in vitro. Developmental Brain Research 122 1 (2000) 87-90
45. Zigova T., Willing A.E., Saporta S., Daadi M.M., McGrogan M.P., Randall T.S., Freeman T.B., Sanchez-Ramos J., and Sanberg P.R. Apoptosis in cultured hNT neurons. Developmental Brain Research 127 1 (2001) 63-70